- Home
- VLTO vs ICLR Comparison
VLTO vs ICLR Comparison
Compare VLTO & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLTO
- ICLR
- Stock Information
- Founded
- VLTO 2023
- ICLR 1990
- Country
- VLTO United States
- ICLR Ireland
- Employees
- VLTO N/A
- ICLR N/A
- Industry
- VLTO Electrical Products
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- VLTO Industrials
- ICLR Health Care
- Exchange
- VLTO Nasdaq
- ICLR Nasdaq
- Market Cap
- VLTO 27.8B
- ICLR 26.3B
- IPO Year
- VLTO N/A
- ICLR 1998
- Fundamental
- Price
- VLTO $110.40
- ICLR $295.69
- Analyst Decision
- VLTO Buy
- ICLR Strong Buy
- Analyst Count
- VLTO 13
- ICLR 9
- Target Price
- VLTO $104.17
- ICLR $351.67
- AVG Volume (30 Days)
- VLTO 1.3M
- ICLR 548.8K
- Earning Date
- VLTO 10-23-2024
- ICLR 10-23-2024
- Dividend Yield
- VLTO 0.33%
- ICLR N/A
- EPS Growth
- VLTO N/A
- ICLR 39.27
- EPS
- VLTO 3.19
- ICLR 8.61
- Revenue
- VLTO $5,077,000,000.00
- ICLR $8,331,892,000.00
- Revenue This Year
- VLTO $5.12
- ICLR $6.84
- Revenue Next Year
- VLTO $5.49
- ICLR $8.14
- P/E Ratio
- VLTO $34.49
- ICLR $34.86
- Revenue Growth
- VLTO 2.67
- ICLR 5.42
- 52 Week Low
- VLTO $65.51
- ICLR $221.20
- 52 Week High
- VLTO $112.77
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- VLTO 57.09
- ICLR 41.13
- Support Level
- VLTO $107.62
- ICLR $269.08
- Resistance Level
- VLTO $110.77
- ICLR $304.16
- Average True Range (ATR)
- VLTO 1.45
- ICLR 10.06
- MACD
- VLTO -0.43
- ICLR -1.55
- Stochastic Oscillator
- VLTO 49.32
- ICLR 50.75
About VLTO Veralto Corp
Veralto Corp is company which is a provider of essential technology solutions that safeguard many of the world's most vital resources. The company operates in two segments such as Water Quality and Product Quality & Innovation. Through WQ segment it improves the quality and reliability of water through leading brands including Hach, Trojan Technologies and ChemTreat. Through PQI segment it promotes consumer trust in products and help enable product innovation through brands including Videojet, Linx, Esko, X-Rite and Pantone.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.